Toggle navigation
English (United States)
Українська (Україна)
Home
About Us
Alivira at a Glance
Our Philosophy
Our Journey
Leadership
Board of Directors
Products
Formulations
Europe
Germany
Sweden
Belgium & Netherlands
Spain
Emerging Markets
India
Turkey
LATAM
APIs
India
USA
Group Companies
Karizoo
Fendigo
Evance
Bremer
N-vet
Topkim
Provet
Alivira Italia
Manufacturing & RnD
Global Research and Development
Global Manufacturing Facilities
Media
Events
In the news
Photo and Video Gallery
Press Release
Careers
Current Openings
Contact Us
About Us
Our Journey
About Us
Our Journey
Our Journey
Established presence in France
Acquired Bremer Pharma in Germany to boost injectable pipeline in EU
Divestment of human API business
Alivira’s dedicated animal health API facility gets USFDA approval, First US FDA approval for an Indian Animal Health facility
Entry in Nigeria (Poultry)
Establishment of Alivira Ukraine with focus on Eastern Europe and CIS
Entry in Europe through majority stake acquisition in Karizoo (Spain)
Entry in LATAM through majority stake acquisition in Evance (Brazil)
Entry in Taiwan
Strengthened our distribution in Europe through acquisition of two distribution companies N-Vet and Fendigo
Strengthened foothold in India through acquisition of Lyka Animal Health
Entry in Philippines
Strengthened our Large Animal portfolio through majority stakes in Provet
Entry in Myanmar
Started building first of its kind “multi product” API facility at Visakhapatnam(Vizag)
Genesis
Formation of Alivira Animal Health Ltd.
TOP